Text Messages to Help Adolescents and Adults Take Oral Leukemia Chemotherapy
Tests text message reminders to support taking oral chemotherapy in leukemia and lymphoma patients.
Key facts
- Who runs it
- University of Chicago
- Where
- Chicago, United StatesSee the site
- Trial code
- Registry title
- Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia
- Status
- Recruiting
- People taking part
- 48 people, planned
- Started
- 19 May 2026
- Expected to end
- 15 Jun 2028
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- High Intensity
- No Text Messagings
- Low Intensity Text Messaging
- Record updated
- 10 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 15 or older with acute lymphoblastic leukemia (ALL) or T-cell lymphoblastic lymphoma who take oral chemotherapy. It tests whether text messages help them take it.
- Age
- 15 years or older
- Sex
- All sexes can join.
- Disease stage
- Diagnosed with ALL or T-cell lymphoblastic lymphoma, being treated with a regimen that includes a maintenance phase.
- Earlier treatment
- Currently treated with a pediatric-based regimen that includes maintenance with mercaptopurine and methotrexate (for example CALGB 10403). Enrollment is before maintenance starts. In the pilot phase, people may have started maintenance if it ends after the 28-day pilot intervention.
Main reasons for not taking part
- The patient or caregiver who would get the text messages has no cell phone that receives text messages
- The patient does not wish to take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Age of 15 years or older at time of enrollment
- Diagnosed with ALL or T-cell lymphoblastic lymphoma
- Currently receiving treatment with pediatric-based regimen that includes maintenance with mercaptopurine and methotrexate (e.g., CALGB 10403). Study participation begins with the start of maintenance, so enrollment occurs prior to the start of maintenance. Patients in the pilot phase may have already started maintenance as long as the end of their maintenance therapy is scheduled to occur after the end of the 28-day pilot intervention
Who cannot take part
- Patient or caregiver who would receive text message reminders does not have a cell phone that receives text messages
- Patient does not wish to participate
- Text messages will be crafted in the patient's preferred language for medical communication, so English fluency is not an enrollment requirement
Where in United States
- University of Chicago Medicine-Comprehensive Cancer CenterChicago, United StatesContact: Clinical Trials IntakeTaking people
About the trial
What the trial wants to find out
This is a single center 2-phase study to assess effects of using text messages on adherence to oral chemotherapy for patients with acute lymphoblastic leukemia (ALL) or T-cell lymphoblastic lymphoma.
The 3 groups in the trial
- Efficacy Phase: High Intensity MessagingExisting treatment, for comparison
Receives high-intensity text messaging for 2 cycles of treatment
Treatment: High Intensity
- Efficacy Phase: Low Intensity MessagingExisting treatment, for comparison
Receives no texts for 1st cycle and low-intensity texts for 2nd cycle
Treatment: No Text Messagings and Low Intensity Text Messaging
- Pilot Phase ArmTreatment being tested
Participants receive high-intensity text messaging for 28 days
Treatment: High Intensity
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Improving Oral Chemotherapy Adherence in Maintenance for Adolescents and Adults With Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma Using Text Messages
- Plain-language title
- Text Messages to Help Adolescents and Adults Take Oral Leukemia ChemotherapyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 10 July 2026